You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

PARAFON FORTE DSC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Parafon Forte Dsc patents expire, and when can generic versions of Parafon Forte Dsc launch?

Parafon Forte Dsc is a drug marketed by Janssen R And D and is included in one NDA.

The generic ingredient in PARAFON FORTE DSC is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Parafon Forte Dsc

A generic version of PARAFON FORTE DSC was approved as chlorzoxazone by AUROBINDO PHARMA LTD on May 4th, 1988.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PARAFON FORTE DSC?
  • What are the global sales for PARAFON FORTE DSC?
  • What is Average Wholesale Price for PARAFON FORTE DSC?
Summary for PARAFON FORTE DSC
Drug patent expirations by year for PARAFON FORTE DSC

US Patents and Regulatory Information for PARAFON FORTE DSC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen R And D PARAFON FORTE DSC chlorzoxazone TABLET;ORAL 011529-002 Jun 15, 1987 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

PARAFON FORTE DSC Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Parafon Forte DSC (Chlorzoxazone)

Introduction to Parafon Forte DSC

Parafon Forte DSC, known generically as chlorzoxazone, is a skeletal muscle relaxant that has been in use since its FDA approval in 1958. It is primarily used to relieve pain and stiffness caused by muscle strains and sprains, acting on the central nervous system to relax muscles and improve mobility[5].

Market Trends and Utilization

Growing Use of Generic Drugs

The pharmaceutical industry has seen a significant increase in the utilization of generic drugs, a trend that benefits Parafon Forte DSC. With the expiration of patents for several high-cost brand-name drugs, generic alternatives like chlorzoxazone have become more prevalent. In the first half of 2024, generic drug prescriptions have increased by 10%, indicating a growing acceptance and utilization of these cost-effective alternatives[3].

Prescription Drug Spending

Despite regulatory efforts aimed at controlling costs, prescription drug prices have continued to rise. The average drug prices have increased by approximately 5% in the first half of 2024, influenced by factors such as inflation, supply chain disruptions, and the introduction of new high-cost medications. However, generic versions of drugs like chlorzoxazone remain a more affordable option for patients[3].

Pricing and Cost Analysis

Brand Name vs. Generic Pricing

The cost for Parafon Forte DSC (brand name) 500 mg oral tablets can be around $365 for a supply of 100 tablets, which works out to approximately $3.65 per tablet. In contrast, the generic version of chlorzoxazone is significantly cheaper, with prices starting from around $10.47 for 8 tablets, or less than $0.27 per day for the generic version[2][5].

Patient Assistance and Copay Programs

To make Parafon Forte DSC more accessible, patient assistance programs (PAPs) and copay cards are available. For example, the Rx Outreach Medications program offers Parafon Forte DSC at a reduced cost, with some medications available for a fee of $20 for up to a 180-day supply. Additionally, discount cards like the Drugs.com Discount Card can save patients up to 80% on prescription medicines[2].

Financial Trajectory

Impact of Regulatory Changes

The Inflation Reduction Act (IRA), aimed at curbing escalating drug prices, has had mixed results. While the Act introduces measures to limit annual price hikes, its broader impact on the market remains to be fully realized. For Parafon Forte DSC, the availability of generic versions helps mitigate the effects of rising brand-name drug prices[3].

Market Competition

Chlorzoxazone competes with other muscle relaxants like Flexeril (cyclobenzaprine). However, its pricing advantage and specific side effect profile make it a preferred option for many patients. For instance, the brand name version of Flexeril can cost around $20-$30 per day, while the generic version of chlorzoxazone is significantly cheaper[5].

Patient Feedback and Efficacy

User Reviews and Experiences

Patient reviews indicate that Parafon Forte DSC is effective for many users. For example, one user reported using the generic form of Parafon Forte DSC since 1997 for back, neck, and leg spasms due to fibromyalgia and sciatica, finding it more effective than other muscle relaxants like Flexeril and Soma. Another user noted that it provided significant relief from severe muscle spasms and pain due to spinal conditions and neuropathy, despite occasional headaches[1].

Side Effects and Contraindications

While generally well-tolerated, Parafon Forte DSC can have serious side effects such as hepatic toxicity, including jaundice, and severe skin reactions like Stevens-Johnson syndrome. It should not be taken with alcohol or CNS depressants and is not recommended for patients with liver disease[5].

Conclusion

Parafon Forte DSC (chlorzoxazone) remains a viable option in the market for muscle relaxants due to its efficacy, relatively low cost, especially in its generic form, and specific mechanism of action. As the pharmaceutical industry continues to evolve with rising drug prices and increased utilization of generic drugs, chlorzoxazone is likely to maintain its market presence.

Key Takeaways

  • Generic Drug Utilization: The use of generic drugs, including chlorzoxazone, has increased significantly, offering cost-effective alternatives.
  • Pricing: The generic version of chlorzoxazone is substantially cheaper than the brand name, making it more accessible.
  • Patient Assistance: Various patient assistance programs and discount cards help reduce the cost of Parafon Forte DSC.
  • Efficacy: Patient reviews highlight the effectiveness of chlorzoxazone in relieving muscle spasms and pain.
  • Side Effects: Serious side effects include hepatic toxicity and severe skin reactions, necessitating careful use.

FAQs

Q: What is Parafon Forte DSC used for?

Parafon Forte DSC (chlorzoxazone) is used to relieve pain and stiffness caused by muscle strains and sprains.

Q: How much does Parafon Forte DSC cost?

The cost for Parafon Forte DSC can range from approximately $365 for 100 brand-name tablets to less than $0.27 per day for the generic version.

Q: Are there any patient assistance programs available for Parafon Forte DSC?

Yes, programs like Rx Outreach Medications and discount cards like the Drugs.com Discount Card can help reduce the cost.

Q: What are the potential side effects of Parafon Forte DSC?

Serious side effects include hepatic toxicity, severe skin reactions, and interactions with alcohol or CNS depressants.

Q: How does Parafon Forte DSC compare to other muscle relaxants like Flexeril?

Parafon Forte DSC is generally cheaper and has a different side effect profile compared to Flexeril, making it a preferred option for some patients.

Sources

  1. Drugs.com: Chlorzoxazone Reviews & Ratings.
  2. Drugs.com: Parafon Forte DSC Prices, Coupons, Copay Cards & Patient Assistance.
  3. intercept.health: Drug Trend Report (Q1-Q2 2024).
  4. ACS Publications: A Coarse-Grained Molecular Dynamics Perspective on the Release.
  5. WithPower: Chlorzoxazone vs Flexeril.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.